Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Rubitecan

EU orphan designation number: EU/3/03/145   
Active ingredient: Rubitecan
Indication: Treatment of pancreatic cancer
Sponsor: Eurogen Pharmaceuticals Limited
1st Floor, Eagle Tower, Montpellier Drive, Cheltenham, Gloucestershire GL50 1TA, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/06/2003 Orphan designation EMEA/OD/068/02 (2003)1881 of 10/06/2003